Comprehensive Study Guide on Chromosomal Mutations, Gene Repair, and DNA Technology

Chromosomal Mutations: Karyotypes and Structural Rearrangements

• Karyotype Definition: A karyotype represents the complete set of chromosomes in an organism, where the morphology of the chromosomes is made visible.     * In a normal karyotype, chromosomes are typically paired and organized by size and shape.     * Advanced visualization involves probing each chromosome with a different color; in cancer cells, these karyotypes often appear highly disorganized with multiple colors on single chromosomes, indicating complex rearrangements.
• Aneuploidy and Polyploidy:     * Aneuploidy: A variation in chromosome number characterized by having one extra or one missing chromosome (e.g., trisomy or monosomy).     * Polyploidy: Variation involving the addition of an entire new set of chromosomes.
• Types of Chromosomal Rearrangements:     * Deletions: Portions of the chromosome are lost, often due to double-strand DNA breaks. A single break can lead to segments being lost and degraded. If two breaks occur, the internal segment is lost, and the ends are rejoined.     * Duplications: Portions of the chromosome are repeated. This often occurs during meiosis due to repetitive sequences leading to misaligned crossover events (nonallelic recombination). One chromatid gains a duplication while the other sustains a deletion.     * Inversions: DNA segments flip and change position on the same chromosome. These can be pericentric (including the centromere) or paracentric (occurring outside the centromere).     * Translocations: These occur when non-homologous chromosomes exchange DNA.         * Reciprocal Translocations: The same number of genes are present but in different positions on different chromosomes.         * Non-reciprocal Translocations: Movement of DNA from one chromosome to another without mutual exchange.

Effects of Rearrangements on Gene Expression and Diseases

• Position Dependent and Dosage Dependent Effects:     * Rearrangements can lead to gene dosage imbalances where there is too much or too little of a gene product.     * Position Effect: Even if the gene sequence is intact, moving it near different regulatory elements (like enhancers or heterochromatin) can drastically alter its expression level.
• Case Study: Burkitt’s Lymphoma:     * This cancer of the lymphatic/immune system is associated with translocations between the $c-myc$ locus on chromosome 8 and Immunoglobulin (Ig) genes ($IgH$, $Igκ$, $Igλ$) on chromosomes 14, 2, and 22 respectively.     * The $c-myc$ gene encodes a protein that promotes cell growth. When translocated near highly expressed Ig genes in B lymphocytes, $c-myc$ is overexpressed, leading to uncontrolled cell growth.
• Case Study: Familial Down Syndrome:     * Caused by a non-reciprocal translocation between Chromosome 14 and Chromosome 21 (forming a 14-21 translocation chromosome containing the long arms of both).     * Gamete Formation Outcomes:         * Normal: Two separate chromosomes (14 and 21).         * Balanced Carrier: One normal 14, one 14-21 translocation, and no separate 21. Phenotypically normal but carries the risk for offspring.         * Familial Down Syndrome: One normal 14, one 14-21 translocation, and one normal 21 (effectively trisomy 21).         * Unbalanced/Lethal: Gametes missing essential segments or having lethal trisomies/monosomies.

Evolutionary Impacts and Gene Families

• Gene Duplication and Paralogs: Duplications allow essential genes to remain functional while the new copy is "free" to mutate and potentially gain new functions. These homologous genes within a single species are called paralogs.
• Globin Gene Family Evolution: Over millions of years, an ancestral globin gene duplicated into primordial myoglobin and primordial hemoglobin. Further duplications led to the $α$-chain and $β$-chain families.
• Table 8.1: Globin Gene Expression During Human Development:     * Embryo: Expresses $ε$-globin and $ζ$-globin; Composition: Two $ε$ and two $ζ$; $P_{50}$: $5-13.5 mmHg$.     * Fetus: Expresses $γ$-globin and $α$-globin; Composition: Two $γ$ and two $α$; $P_{50}$: $19.5 mmHg$.     * Birth to Adult: Expresses $β$-globin and $α$-globin; Composition: Two $β$ and two $α$; $P_{50}$: $26.5 mmHg$.
• Speciation: Deletions, inversions, and translocations can lead to gamete incompatibility over time, driving the formation of new species.

Non-disjunction and Human Aneuploidy

• Non-disjunction Mechanisms:     * Meiosis I: Failure of homologous chromosomes to separate. Results in $n+1$, $n+1$, $n-1$, and $n-1$ gametes.     * Meiosis II: Failure of sister chromatids to separate. Results in $n+1$, $n-1$, $n$, and $n$ gametes.     * Mitosis: Failure of spindle checkpoint during metaphase, leading to aneuploidy in daughter cells (common in tumors).
• Maternal Age and Down Syndrome Incidence:     * Age 20: $1/1925$     * Age 30: $1/885$     * Age 35: $1/365$     * Age 45: $1/32$     * Age 50: $1/12$
• Table 8.3: Aneuploid Conditions in Humans:     * Patau Syndrome: Trisomy 13 ($1/15,000$); characteristics include mental/physical deficiencies, organ defects, early death.     * Edward Syndrome: Trisomy 18 ($1/6000$); characteristics include muscle tone issues, facial abnormalities, early death.     * Down Syndrome: Trisomy 21 ($1/800$); characteristics include mental deficiencies, slanted eyes, short stature.     * Klinefelter Syndrome: XXY ($1/1000$ males); sexual immaturity, breast swelling.     * Jacobs Syndrome: XYY ($1/1000$ males); tall and thin.     * Triple X Syndrome: XXX ($1/1500$ females); tall and thin, menstrual irregularity.     * Turner Syndrome: XO ($1/5000$ females); short stature, webbed neck, sexually undeveloped.

Gene Mutations: Types and Consequences

• Somatic vs. Germline Mutations:     * Somatic: Occur in non-gonad tissues; not passed to offspring.     * Germline: Occur in gametes; affect the next generation.
• Table 19.1: Point Mutations in Coding Sequences:     * Silent: Base substitution results in the same amino acid. Effect: None.     * Missense: Base substitution results in a different amino acid (e.g., Met to Pro). Effect: Neutral or inhibitory.     * Nonsense: Base substitution creates a STOP codon. Effect: Negative (truncated protein).     * Frameshift: Addition or deletion of nucleotides (not in multiples of 3). Effect: Negative (entire downstream sequence altered).
• Table 19.2: Mutations Outside Coding Sequences:     * Promoter: Changes transcription rate.     * Enhancer/Operator: Disrupts regulation.     * 5'-UTR/3'-UTR: Affects translation or mRNA stability.     * Splice recognition: Alters pre-mRNA splicing.
• Case Study: Sickle Cell Disease: A base substitution in the $\beta$-globin gene (GAG to GTG) changes the 6th amino acid from Glutamic Acid (Glu) to Valine (Val), causing hemoglobin to aggregate and red blood cells to sickle.
• Suppressor Mutations: New mutations that revert a phenotype back to wild-type.     * Intragenic: Mutation within the same gene.     * Intergenic (Extragenic): Mutation in a different gene (e.g., restoring a protein-protein interaction).

Causes of Mutations and DNA Repair

• Spontaneous Mutations:     * Tautomeric Shifts: Rare shifts in base structure (e.g., Thymine shifting) prior to replication lead to mismatches (T:G). After a second round of replication, this becomes a permanent mutation (C:G).     * Depurination/Deamination: Loss of purine bases or conversion of Cytosine to Uracil.     * Trinucleotide Repeat Expansion (TNRE): Repeated sequences (like CTG) cause DNA polymerase to slip, forming a hairpin loop in the daughter strand. This results in the sequence getting longer with each replication.
• Induced Mutations:     * Chemical: Agents like Nitrous acid ($HNO_2$) modify bases (e.g., Cytosine to Uracil), changing base-pairing rules.     * Physical: UV radiation causes Thymine dimers (covalent bonds between adjacent Timines), which stall DNA polymerase.
• Repair Mechanisms:     * Nucleotide Excision Repair (NER):         * UvrA/UvrB: Recognize damage.         * UvrC: Endonuclease that cuts the DNA on both sides of the damage.         * UvrD: Helicase that removes the damaged strand.         * DNA Polymerase and Ligase: Fill and seal the gap.     * Double Strand Break (DSB) Repair:         * Homologous Recombination (HR): Occurs in S or G2 phase; uses sister chromatid as a template for error-free repair.         * Non-Homologous End Joining (NHEJ): Occurs in G1 phase; uses a protein crossbridge to join ends. This is error-prone (potentially mutagenic) as it may involve trimming ends.

Biotechnology and DNA Analysis Techniques

• Cloning Vectors (Plasmids): Circular DNA used to carry foreign genetic material.     * Example: pET28a is an inducible vector used for high-level protein expression.     * Features: Origin of replication ($ori$), antibiotic resistance gene, multiple cloning site ($MCS$), and inducible promoters/operators.
• Restriction Enzymes: Cut DNA at specific sequences, creating "sticky ends" or overhangs that allow for ligation into vectors to create recombinant DNA.
• Reverse Transcription (RT): Uses Reverse Transcriptase to turn mRNA into complementary DNA (cDNA), allowing for the study of gene expression and protein function.
• Polymerase Chain Reaction (PCR):     * Used to amplify specific DNA regions using primers.     * Steps: 1. Denaturation (heat), 2. Annealing (primers bind), 3. Extension (DNA pol synthesis).     * Process is exponential: $2^n$ copies where $n$ is the number of cycles.
• Sanger Sequencing (Chain Termination): Uses dideoxynucleotides (ddNTPs) which lack a $3'-OH$ group, preventing further chain elongation. Each ddNTP is fluorescently labeled for detection.
• CRISPR/Cas9 Genome Editing:     * Researcher designs a guide RNA (tracrRNA + target-specific crRNA).     * Cas9 Nuclease creates a DSB at the target site.     * The break is repaired by NHEJ (to create knockouts) or HR (to introduce specific mutations using a template).